Medicare Enrolled

Dr. Roy Herbst, M.D., PHD

Medical Oncology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
Registered in NPPES since 2006
NPI: 1619060498 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Herbst from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Herbst? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Herbst

Dr. Roy Herbst is a medical oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Herbst performed 15 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Herbst received a total of $1,475,419 from 46 pharmaceutical and/or device companies across 522 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Herbst is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 15 Medicare services $1,475,419 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
15
Medicare services
Not available
Unique patients (not deduplicated)
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $115 $495
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,475,419
Total received (2018-2024)
Avg $210,774/year across 7 years
Top 1% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
522
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$586,664
2023
$495,400
2022
$85,730
2021
$63,817
2020
$44,592
2019
$108,345
2018
$90,871

Payments by company (2024)

Immunocore Limited
$496,768
Merck Sharp & Dohme LLC
$32,277
Regeneron Pharmaceuticals, Inc.
$21,351
F. Hoffmann-La Roche AG
$14,241
AstraZeneca Pharmaceuticals LP
$9,885
Dr.Reddy's Laboratories,Inc.
$3,000
SANOFI US SERVICES INC.
$2,895
GlaxoSmithKline, LLC.
$2,440
ARRAY BIOPHARMA INC
$1,491
PFIZER INC.
$1,260
Gilead Sciences, Inc.
$760
Janssen Scientific Affairs, LLC
$146
Regeneron Healthcare Solutions, Inc.
$98
Zimmer Biomet Holdings, Inc.
$52
Top 3 companies account for 93.8% of 2024 payments
All-time payments by company (2018-2024) ›
Immunocore Limited
$954,603
Merck Sharp & Dohme Corporation
$82,272
AstraZeneca Pharmaceuticals LP
$50,640
Merck Sharp & Dohme LLC
$49,566
AstraZeneca UK Limited
$41,623
F. Hoffmann-La Roche AG
$34,680
GENZYME CORPORATION
$34,018
Regeneron Pharmaceuticals, Inc.
$32,528
EMD Serono, Inc.
$23,450
Daiichi Sankyo Inc.
$15,768
E.R. Squibb & Sons, L.L.C.
$14,767
Gilead Sciences, Inc.
$13,947
VENTANA MEDICAL SYSTEMS, INC.
$11,886
Eli Lilly and Company
$11,585
Genentech USA, Inc.
$11,324
Amgen Inc.
$7,227
ABBVIE INC.
$7,150
Foundation Medicine, Inc.
$7,131
PFIZER INC.
$7,110
GlaxoSmithKline, LLC.
$6,490
Novartis Pharmaceuticals Corporation
$6,282
Janssen Global Services, LLC
$5,920
Lilly USA, LLC
$4,598
Janssen Scientific Affairs, LLC
$4,186
Novartis Pharma AG
$4,176
Genentech, Inc.
$3,976
Eisai Inc.
$3,750
Dr.Reddy's Laboratories,Inc.
$3,000
SANOFI US SERVICES INC.
$2,895
TESARO, Inc.
$2,808
AbbVie, Inc.
$2,750
Seagen Inc.
$2,500
Blueprint Medicines Corporation
$2,281
SANOFI-AVENTIS U.S. LLC
$1,956
Chugai Pharmaceutical Co., Ltd.
$1,650
ARRAY BIOPHARMA INC
$1,491
Mirati Therapeutics, Inc.
$1,462
Spectrum Pharmaceuticals Inc.
$1,298
Regeneron Healthcare Solutions, Inc.
$226
Bristol-Myers Squibb Company
$114
Bayer HealthCare Pharmaceuticals Inc.
$112
Roche Products Limited
$70
Zimmer Biomet Holdings, Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Taiho Oncology, Inc.
$36
AstraZeneca AB
$18
Top 3 companies account for 73.7% of all-time payments
Associated products mentioned in payments ›
ACZ885V_ILARIS_IMMUNOLOGY · ALIMTA · Alecensa · BAVENCIO · BENCHMARK IHC/ISH PLATFORMS & REAGENTS · BRAFTOVI · Bavencio · CYRAMZA · FOUNDATIONACT · FOUNDATIONONE CDX · ILARIS · IMFINZI · KEYTRUDA · KIMMTRAK · KRAZATI · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · Non-Covered Product · OPDIVO · RETACRIT · RYBREVANT · SAR408701 · TAGRISSO · TECENTRIQ · Tecentriq · Trabecular Metal · Trodelvy · VENTANA RESEARCH & DEVELOPMENT
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Houston?
Compare medical oncologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
185
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Herbst is a clinical cardiology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Herbst experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Herbst performed 15 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Herbst receive payments from pharmaceutical companies?
Yes. Dr. Herbst received a total of $1,475,419 from 46 companies across 522 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Herbst's costs compare to other medical oncologists in Houston?
Dr. Herbst's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Herbst) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →